Skip to main content
Top
Published in: BMC Health Services Research 1/2010

Open Access 01-12-2010 | Study protocol

Effects of prescription adaptation by pharmacists

Authors: Michael R Law, Steven G Morgan, Sumit R Majumdar, Larry D Lynd, Carlo A Marra

Published in: BMC Health Services Research | Issue 1/2010

Login to get access

Abstract

Background

Granting dispensing pharmacists the authority to prescribe has significant implications for pharmaceutical and health human resources policy, and quality of care. Despite the growing number of jurisdictions that have given pharmacists such privileges, there are few rigorous evaluations of these policy changes. This study will examine a January 2009 policy change in British Columbia (BC), Canada that allowed pharmacists to independently adapt and renew prescriptions. We hypothesize this policy increased drug utilization and drug costs, increased patient adherence to medication, and reduced total healthcare resource use.

Methods/Design

We will study a population-based cohort of approximately 4 million BC residents from 2004 through 2010. We will use data from BC PharmaNet on all of the prescriptions obtained by this cohort during the study period, and link it to administrative billings from physicians and hospital discharges. Using interrupted time series analysis, we will study longitudinal changes in drug utilization and costs, medication adherence, and short-term health care use. Further, using hierarchical modelling, we will examine the factors at the regional, pharmacy, patient, and prescription levels that are associated with prescription adaptations and renewals.

Discussion

In a recent survey of Canadian policymakers, many respondents ranked the issue of prescribing privileges as one of their most pressing policy questions. No matter the results of our study, they will be important for policymakers, as our data will make policy decisions surrounding pharmacist prescribing more evidence-based.
Appendix
Available only for authorised users
Literature
1.
go back to reference Glazier RH, Klein-Geltink J, Kopp A, Sibley LM: Capitation and enhanced fee-for-service models for primary care reform: a population-based evaluation. CMAJ. 2009, 180: E72-81.CrossRefPubMedPubMedCentral Glazier RH, Klein-Geltink J, Kopp A, Sibley LM: Capitation and enhanced fee-for-service models for primary care reform: a population-based evaluation. CMAJ. 2009, 180: E72-81.CrossRefPubMedPubMedCentral
2.
go back to reference Nkansah N, Mostovetsky O, Yu C, Chheng T, Beney J, Bond CM, Bero L: Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database of Systematic Reviews. 2010, The Cochrane Collaboration, Bero L Chichester, UK: John Wiley & Sons, Ltd Nkansah N, Mostovetsky O, Yu C, Chheng T, Beney J, Bond CM, Bero L: Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database of Systematic Reviews. 2010, The Cochrane Collaboration, Bero L Chichester, UK: John Wiley & Sons, Ltd
3.
go back to reference Yuksel N, Eberhart G, Bungard TJ: Prescribing by pharmacists in Alberta. Am J Health Syst Pharm. 2008, 65: 2126-2132. 10.2146/ajhp080247.CrossRefPubMed Yuksel N, Eberhart G, Bungard TJ: Prescribing by pharmacists in Alberta. Am J Health Syst Pharm. 2008, 65: 2126-2132. 10.2146/ajhp080247.CrossRefPubMed
4.
go back to reference Tonna AP, Stewart D, West B, McCaig D: Pharmacist prescribing in the UK - a literature review of current practice and research. J Clin Pharm Ther. 2007, 32: 545-556. 10.1111/j.1365-2710.2007.00867.x.CrossRefPubMed Tonna AP, Stewart D, West B, McCaig D: Pharmacist prescribing in the UK - a literature review of current practice and research. J Clin Pharm Ther. 2007, 32: 545-556. 10.1111/j.1365-2710.2007.00867.x.CrossRefPubMed
5.
go back to reference Cooper R, Anderson C, Avery T, Bissell P, Guillaume L, Hutchinson A, Lymn J, Murphy E, Ratcliffe J, Ward P: Stakeholders' views of UK nurse and pharmacist supplementary prescribing. J Health Serv Res Policy. 2008, 13: 215-221. 10.1258/jhsrp.2008.008004.CrossRefPubMed Cooper R, Anderson C, Avery T, Bissell P, Guillaume L, Hutchinson A, Lymn J, Murphy E, Ratcliffe J, Ward P: Stakeholders' views of UK nurse and pharmacist supplementary prescribing. J Health Serv Res Policy. 2008, 13: 215-221. 10.1258/jhsrp.2008.008004.CrossRefPubMed
6.
go back to reference Cooper RJ, Lymn J, Anderson C, Avery A, Bissell P, Guillaume L, Hutchinson A, Murphy E, Ratcliffe J, Ward P: Learning to prescribe - pharmacists' experiences of supplementary prescribing training in England. BMC Med Educ. 2008, 8: 57. 10.1186/1472-6920-8-57. Cooper RJ, Lymn J, Anderson C, Avery A, Bissell P, Guillaume L, Hutchinson A, Murphy E, Ratcliffe J, Ward P: Learning to prescribe - pharmacists' experiences of supplementary prescribing training in England. BMC Med Educ. 2008, 8: 57. 10.1186/1472-6920-8-57.
7.
go back to reference Blenkinsopp A, Tann J, Evans A, Grime J: Opportunity or threat? General practitioner perceptions of pharmacist prescribing. International Journal of Pharmacy Practice. 2008, 16: 29-34. 10.1211/ijpp.16.1.0006.CrossRef Blenkinsopp A, Tann J, Evans A, Grime J: Opportunity or threat? General practitioner perceptions of pharmacist prescribing. International Journal of Pharmacy Practice. 2008, 16: 29-34. 10.1211/ijpp.16.1.0006.CrossRef
8.
go back to reference Morgan S, Raymond C, Mooney D, Martin D: The Canadian Rx Atlas. 2008, Vancouver, BC: Centre for Health Services and Policy Research, University of British Columbia Morgan S, Raymond C, Mooney D, Martin D: The Canadian Rx Atlas. 2008, Vancouver, BC: Centre for Health Services and Policy Research, University of British Columbia
9.
go back to reference Canadian Institute for Health Information: Health Care in Canada. 2008, Ottawa, Ontario: Cana Canadian Institute for Health Information: Health Care in Canada. 2008, Ottawa, Ontario: Cana
10.
go back to reference Osterberg L, Blaschke T: Adherence to Medication. N Engl J Med. 2005, 353: 487-497. 10.1056/NEJMra050100.CrossRefPubMed Osterberg L, Blaschke T: Adherence to Medication. N Engl J Med. 2005, 353: 487-497. 10.1056/NEJMra050100.CrossRefPubMed
11.
go back to reference Meyer B, Hill J, Trujillo G: Attaining pharmacist recognition in the United States. Am J Health Syst Pharm. 2008, 65: 2152-2153. 10.2146/ajhp080515.CrossRefPubMed Meyer B, Hill J, Trujillo G: Attaining pharmacist recognition in the United States. Am J Health Syst Pharm. 2008, 65: 2152-2153. 10.2146/ajhp080515.CrossRefPubMed
14.
go back to reference Hepler C, Strand L: Opportunities and responsibilities in pharmaceutical care. Am J Health Syst Pharm. 1990, 47: 533-543. Hepler C, Strand L: Opportunities and responsibilities in pharmaceutical care. Am J Health Syst Pharm. 1990, 47: 533-543.
19.
go back to reference Canadian Institute for Health Information: National Health Expenditure Trends: 1975 to 2009. 2009, Ottawa, Ontario: Canadian Institute for Health Information Canadian Institute for Health Information: National Health Expenditure Trends: 1975 to 2009. 2009, Ottawa, Ontario: Canadian Institute for Health Information
20.
go back to reference Canadian Institute for Health Information: Drug Expenditure in Canada. 2009, Ottawa, Ontario: Canadian Institute for Health Information Canadian Institute for Health Information: Drug Expenditure in Canada. 2009, Ottawa, Ontario: Canadian Institute for Health Information
21.
go back to reference Morgan S, Hanley GE, Cunningham C, Mooney D: BC Rx Atlas. 2009, Vancouver, BC: Centre for Health Services and Policy Research, University of British Columbia, 2 Morgan S, Hanley GE, Cunningham C, Mooney D: BC Rx Atlas. 2009, Vancouver, BC: Centre for Health Services and Policy Research, University of British Columbia, 2
22.
go back to reference Schneeweiss S, Walker AM, Glynn RJ, Maclure M, Dormuth C, Soumerai SB: Outcomes of Reference Pricing for Angiotensin-Converting-Enzyme Inhibitors. N Engl J Med. 2002, 346: 822-829. 10.1056/NEJMsa003087.CrossRefPubMed Schneeweiss S, Walker AM, Glynn RJ, Maclure M, Dormuth C, Soumerai SB: Outcomes of Reference Pricing for Angiotensin-Converting-Enzyme Inhibitors. N Engl J Med. 2002, 346: 822-829. 10.1056/NEJMsa003087.CrossRefPubMed
23.
go back to reference Grootendorst PV, Dolovich LR, O'Brien BJ, Holbrook AM, Levy AR: Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs. CMAJ. 2001, 165: 1011-1019.PubMedPubMedCentral Grootendorst PV, Dolovich LR, O'Brien BJ, Holbrook AM, Levy AR: Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs. CMAJ. 2001, 165: 1011-1019.PubMedPubMedCentral
25.
go back to reference Hanley G, Morgan S: On the validity of area-based income measures to proxy household income. BMC Health Services Research. 2008, 8: 79-10.1186/1472-6963-8-79.CrossRefPubMedPubMedCentral Hanley G, Morgan S: On the validity of area-based income measures to proxy household income. BMC Health Services Research. 2008, 8: 79-10.1186/1472-6963-8-79.CrossRefPubMedPubMedCentral
26.
go back to reference Morgan S, Hanley GE, Cunningham C, Mooney D: BC Rx Atlas. 2009, Vancouver, BC: Centre for Health Services and Policy Research, University of British Columbia, 2 Morgan S, Hanley GE, Cunningham C, Mooney D: BC Rx Atlas. 2009, Vancouver, BC: Centre for Health Services and Policy Research, University of British Columbia, 2
28.
go back to reference Marshall JK, Grootendorst PV, O'Brien BJ, Dolovich LR, Holbrook AM, Levy AR: Impact of reference-based pricing for histamine-2 receptor antagonists and restricted access for proton pump inhibitors in British Columbia. CMAJ. 2002, 166: 1655-1662.PubMedPubMedCentral Marshall JK, Grootendorst PV, O'Brien BJ, Dolovich LR, Holbrook AM, Levy AR: Impact of reference-based pricing for histamine-2 receptor antagonists and restricted access for proton pump inhibitors in British Columbia. CMAJ. 2002, 166: 1655-1662.PubMedPubMedCentral
29.
go back to reference Grootendorst PV, Dolovich LR, O'Brien BJ, Holbrook AM, Levy AR: Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs. CMAJ. 2001, 165: 1011-1019.PubMedPubMedCentral Grootendorst PV, Dolovich LR, O'Brien BJ, Holbrook AM, Levy AR: Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs. CMAJ. 2001, 165: 1011-1019.PubMedPubMedCentral
30.
go back to reference Schneeweiss S, Walker AM, Glynn RJ, Maclure M, Dormuth C, Soumerai SB: Outcomes of Reference Pricing for Angiotensin-Converting-Enzyme Inhibitors. N Engl J Med. 2002, 346: 822-829. 10.1056/NEJMsa003087.CrossRefPubMed Schneeweiss S, Walker AM, Glynn RJ, Maclure M, Dormuth C, Soumerai SB: Outcomes of Reference Pricing for Angiotensin-Converting-Enzyme Inhibitors. N Engl J Med. 2002, 346: 822-829. 10.1056/NEJMsa003087.CrossRefPubMed
32.
go back to reference Reid R, MacWilliam L, Roos N, Bogdanovic B, Black C: Measuring Morbidity in Populations: Performance of the Johns Hopkins Adjusted Clinical Group (ACG) Case-mix Adjustment System in Manitoba. 1999, Winnepeg, Manitoba: Manitoba Centre for Health Policy and Evaluation, Dept. of Community Health Services, Faculty of Medicine Reid R, MacWilliam L, Roos N, Bogdanovic B, Black C: Measuring Morbidity in Populations: Performance of the Johns Hopkins Adjusted Clinical Group (ACG) Case-mix Adjustment System in Manitoba. 1999, Winnepeg, Manitoba: Manitoba Centre for Health Policy and Evaluation, Dept. of Community Health Services, Faculty of Medicine
33.
go back to reference Wagner A, Soumerai S, Zhang F, Ross-Degnan D: Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002, 27: 299-309. 10.1046/j.1365-2710.2002.00430.x.CrossRefPubMed Wagner A, Soumerai S, Zhang F, Ross-Degnan D: Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002, 27: 299-309. 10.1046/j.1365-2710.2002.00430.x.CrossRefPubMed
34.
go back to reference Zhang F, Wagner A, Soumerai S, Rossdegnan D: Methods for estimating confidence intervals in interrupted time series analyses of health interventions. Journal of Clinical Epidemiology. 2009, 62: 143-148. 10.1016/j.jclinepi.2008.08.007.CrossRefPubMed Zhang F, Wagner A, Soumerai S, Rossdegnan D: Methods for estimating confidence intervals in interrupted time series analyses of health interventions. Journal of Clinical Epidemiology. 2009, 62: 143-148. 10.1016/j.jclinepi.2008.08.007.CrossRefPubMed
35.
go back to reference Rubin DB: Estimating Causal Effects from Large Data Sets Using Propensity Scores. Annals of Internal Medicine. 1997, 127: 757-763.CrossRefPubMed Rubin DB: Estimating Causal Effects from Large Data Sets Using Propensity Scores. Annals of Internal Medicine. 1997, 127: 757-763.CrossRefPubMed
36.
go back to reference Beck CA, Williams JVA, Wang JL, Kassam A, El-Guebaly N, Currie SR, Maxwell CJ, Patten SB: Psychotropic medication use in Canada. Can J Psychiatry. 2005, 50: 605-613.PubMed Beck CA, Williams JVA, Wang JL, Kassam A, El-Guebaly N, Currie SR, Maxwell CJ, Patten SB: Psychotropic medication use in Canada. Can J Psychiatry. 2005, 50: 605-613.PubMed
37.
go back to reference Morgan S, Cunningham C: Needs, Gaps and Opportunities Assessment - Emerging Themes. Presentation at the Pharmaceutical Policy Research Collaboration meeting. 2009, Vancouver, BC Morgan S, Cunningham C: Needs, Gaps and Opportunities Assessment - Emerging Themes. Presentation at the Pharmaceutical Policy Research Collaboration meeting. 2009, Vancouver, BC
Metadata
Title
Effects of prescription adaptation by pharmacists
Authors
Michael R Law
Steven G Morgan
Sumit R Majumdar
Larry D Lynd
Carlo A Marra
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2010
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/1472-6963-10-313

Other articles of this Issue 1/2010

BMC Health Services Research 1/2010 Go to the issue